Helicobacter pylori seroprevalence and its association with prevalent and incident blood pressure and haemoglobin A1c in the US-based National Longitudinal Study of Adolescent to Adult Health.
코호트
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
4600 participants; 958 (20.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This cross-sectional and longitudinal study examined whether seropositivity was associated with elevated blood pressure (BP), haemoglobin A1c (HbA1c), prevalent and incident HTN, and T2D over 10 years.
[INTRODUCTION] Chronic () infection may increase the risk of hypertension (HTN) and type 2 diabetes mellitus (T2D), but association studies have produced mixed results.
- 표본수 (n) 15
- 95% CI -3.06 to -0.18
- 연구 설계 cross-sectional
APA
Mendoza CE, Aiello AE, et al. (2026). Helicobacter pylori seroprevalence and its association with prevalent and incident blood pressure and haemoglobin A1c in the US-based National Longitudinal Study of Adolescent to Adult Health.. BMJ public health, 4(1), e003098. https://doi.org/10.1136/bmjph-2025-003098
MLA
Mendoza CE, et al.. "Helicobacter pylori seroprevalence and its association with prevalent and incident blood pressure and haemoglobin A1c in the US-based National Longitudinal Study of Adolescent to Adult Health.." BMJ public health, vol. 4, no. 1, 2026, pp. e003098.
PMID
41736806 ↗
Abstract 한글 요약
[INTRODUCTION] Chronic () infection may increase the risk of hypertension (HTN) and type 2 diabetes mellitus (T2D), but association studies have produced mixed results. This cross-sectional and longitudinal study examined whether seropositivity was associated with elevated blood pressure (BP), haemoglobin A1c (HbA1c), prevalent and incident HTN, and T2D over 10 years.
[METHODS] Add Health, a US-based cohort study, has followed participants from adolescence in the mid-1990s (wave I) through early midlife (wave V) in 2016-2018. Wave IV (n=15 701) participants were tested for immunoglobulin antibodies to with a binary seropositivity cut-off (≥13.217 U/mL). Systolic BP (SBP), diastolic BP (DBP) and HbA1c were measured at waves IV and V. Prevalent HTN was defined as SBP ≥140 mm Hg and/or DBP ≥90 mm Hg, self-reported HTN or HTN medication use at wave IV. Prevalent T2D was defined as HbA1c ≥6.5%, self-reported T2D or T2D medication use at wave IV. Incident HTN and T2D at wave V were defined among participants without HTN or T2D at wave IV. Multivariable linear and Poisson regression models determined prevalence differences (PD) and incidence rate ratios, respectively, with 95% CIs.
[RESULTS] The median (IQR) ages in waves IV and V were 28 (27, 30) and 37 (36, 39) years, respectively, with 54% female in 4600 participants; 958 (20.8%) were seropositive for . In adjusted models, seropositive participants had lower mean SBP (PD -1.62, 95% CI -3.06 to -0.18) than seronegative participants. seropositivity was not associated with DBP, HbA1c, prevalent and incident HTN, or T2D.
[CONCLUSIONS] In a cohort of younger adults, seropositivity was not associated with prevalent or incident HTN and T2D. More studies are required to understand the interaction between infectious disease and chronic cardiometabolic disorders and how it can change as people age.
[METHODS] Add Health, a US-based cohort study, has followed participants from adolescence in the mid-1990s (wave I) through early midlife (wave V) in 2016-2018. Wave IV (n=15 701) participants were tested for immunoglobulin antibodies to with a binary seropositivity cut-off (≥13.217 U/mL). Systolic BP (SBP), diastolic BP (DBP) and HbA1c were measured at waves IV and V. Prevalent HTN was defined as SBP ≥140 mm Hg and/or DBP ≥90 mm Hg, self-reported HTN or HTN medication use at wave IV. Prevalent T2D was defined as HbA1c ≥6.5%, self-reported T2D or T2D medication use at wave IV. Incident HTN and T2D at wave V were defined among participants without HTN or T2D at wave IV. Multivariable linear and Poisson regression models determined prevalence differences (PD) and incidence rate ratios, respectively, with 95% CIs.
[RESULTS] The median (IQR) ages in waves IV and V were 28 (27, 30) and 37 (36, 39) years, respectively, with 54% female in 4600 participants; 958 (20.8%) were seropositive for . In adjusted models, seropositive participants had lower mean SBP (PD -1.62, 95% CI -3.06 to -0.18) than seronegative participants. seropositivity was not associated with DBP, HbA1c, prevalent and incident HTN, or T2D.
[CONCLUSIONS] In a cohort of younger adults, seropositivity was not associated with prevalent or incident HTN and T2D. More studies are required to understand the interaction between infectious disease and chronic cardiometabolic disorders and how it can change as people age.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Correction: Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012-2023).
- Patterns and prognostic implications of cutaneous metastasis in Hong Kong: A multicenter analysis.
- Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives.
- Surgical management of concomitant lung cancer and cardiovascular diseases: a multidisciplinary perspective.
- Enhancing access to treatment and programmes for viral hepatitis in an endemic country: a narrative review of literature from 2000 to 2025 (Mongolia).
- Mastitis as a risk factor for breast cancer: a systematic review and meta-analysis.